[HTML][HTML] Incessant ovulation and ovarian cancer–a hypothesis re-visited
MF Fathalla - Facts, views & vision in ObGyn, 2013 - ncbi.nlm.nih.gov
Ovarian cancer continues to be a silent killer. Most women have advanced disease at the
time of diagnosis. Intensive efforts to develop effective screening strategies have not so far …
time of diagnosis. Intensive efforts to develop effective screening strategies have not so far …
Ovarian cancer genetics: Subtypes and risk factors
J Hirst, J Crow, A Godwin - Ovarian Cancer. Pathog. Treat, 2018 - books.google.com
The genetics of ovarian cancer are a complex, ever evolving concept that presents hurdles
in classification, diagnosis, and treatment in the clinic. Instead of common driver mutations …
in classification, diagnosis, and treatment in the clinic. Instead of common driver mutations …
[PDF][PDF] Study on the VEGF gene expression and the role of PMSG hormone in the development of endometrial cancer in mice
SH Kim, NH Jung, MG Oh… - Journal of Animal …, 2020 - e-sciencecentral.org
In this study, we investigated whether infusion of colorectal cancer cell line and PMSG could
increase endometrial cancer. As a result, our study confirmed that the injection of colorectal …
increase endometrial cancer. As a result, our study confirmed that the injection of colorectal …
Identifying opportunities for improving epithelial ovarian cancer survival using novel approaches for exploring the role of ovulation and hormone-related conditions
Z Fu - 2022 - search.proquest.com
Ovarian cancer is the most lethal gynecologic cancer. Epithelial ovarian cancer (EOC)
accounts for more than 90% of ovarian cancers. Although the etiology of EOC remains …
accounts for more than 90% of ovarian cancers. Although the etiology of EOC remains …